A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma
Fig 1
The workflow of this study involves the use of TCGA-LIHC (The Cancer Genome Atlas Liver Hepatocellular Carcinoma dataset), GSE14520 (GEO dataset), FerrDb (Ferroptosis Database), DEG (Differentially Expressed Genes), and LASSO (Least Absolute Shrinkage and Selection Operator).